Loading...
$733.5K
Awarded Sep 4, 2026
Competition
FULL AND OPEN COMPETITION
Offers
1
Set-Aside
None
Solicitation Type
RFP - Negotiated
Performance Timeline
Start
Sep 11, 2026
Estimated start: Sep 10, 2027
Contract: 75F40126C00098
UEI
JMW6R9VB27L9
Parent Company
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
Capabilities & Certifications
Headquarters Location
Current Obligation
$733,525
Base + Exercised Options
$733,525
Total Ceiling Value
$733,525
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
Description
NEXT GENERATION PROCESS DEVELOPMENT AND QUALITY CONTROL IN PROTEIN LYOPHILIZATION USING MECHANISTIC AND AI APPROACHES
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Awarding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office